miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3

Oncology Reports

Volumn 26, Issue 5, 2011, Pages 1281-1286

  Fan, Chun Guang ^a   Wang, Chun Mei ^a   Tian, Chuan ^a   Wang, Yan ^a   Li, Li ^a   Sun, Wen Sheng ^a   Li, Rui Feng ^a   Liu, Yu Gang ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Hepatitis B virus; Hepatocellular carcinoma; MicroRNAs; miR 122; N myc downstream regulated gene 3

Indexed keywords

HEPATITIS B ANTIGEN; MICRORNA; MICRORNA 122; PROTEIN; PROTEIN NDRG3; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE TARGETING; GENETIC TRANSCRIPTION; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOUSE; N MYC DOWNSTREAM REGULATED GENE 3; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; VIRUS CARCINOGENESIS; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MICRORNAS; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; TRANSFECTION; VIRUS REPLICATION;

EID: 80053136743     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1375     Document Type: Article

References (27)

1. Seeff LB and Hoofnagle JH: Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity. Oncogene 25: 3771-3777, 2006. (Pubitemid 43980472)
2. Thorgeirsson SS and Grisham JW: Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31: 339-346, 2002. (Pubitemid 35154440)
3. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005. (Pubitemid 40372904)
4. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
5. Meister G and Tuschl T: Mechanisms of gene silencing by double-stranded RNA. Nature 431: 343-349, 2004. (Pubitemid 39265674)
6. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
7. Skaftnesmo KO, Prestegarden L, Micklem DR and Lorens JB: MicroRNAs in tumorigenesis. Curr Pharm Biotechnol 8: 320-325, 2007. (Pubitemid 350268190)
8. Lagos-Quintana M, Rauhut R, Lendeckel W and Tuschl T: Identification of novel genes coding for small expressed RNAs. Science 294: 853-858, 2001. (Pubitemid 33032103)
9. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W and Tuschl T: Identification of tissue-specific microRNAs from mouse. Curr Biol 12: 735-739, 2002. (Pubitemid 34455427)
10. Lim LP, Lau NC, Garrett-Engele P, et al: Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773, 2005. (Pubitemid 40292988)
11. Esau C, Davis S, Murray SF, et al: miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3: 87-98, 2006.
12. Bhattacharyya SN, Habermacher R, Martine U, Closs EI and Filipowicz W: Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 125: 1111-1124, 2006. (Pubitemid 43866197)
13. Gramantieri L, Ferracin M, Fornari F, et al: Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 67: 6092-6099, 2007. (Pubitemid 47037488)
14. Bai S, Nasser MW, Wang B, et al: MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J Biol Chem 284: 32015-32027, 2009.
15. Lin CJ, Gong HY, Tseng HC, Wang WL and Wu JL: miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines. Biochem Biophys Res Commun 375: 315-320, 2008.
16. Tsai WC, Hsu PW, Lai TC, et al: MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 49: 1571-1582, 2009.
17. Zhang R, Wang L, Yu GR, Zhang X, Yao LB and Yang AG: MicroRNA-122 might be a double-edged sword in hepatocellular carcinoma. Hepatology 50: 1322-1323, 2009.
18. Lavanchy D: Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11: 97-107, 2004.
19. Barone M, Maiorano E, Ladisa R, et al: Influence of ursodeoxycholate- enriched diet on liver tumor growth in HBV transgenic mice. Hepatology 37: 880-886, 2003. (Pubitemid 36397399)
20. Girard M, Jacquemin E, Munnich A, Lyonnet S and Henrion-Caude A: miR-122, a paradigm for the role of microRNAs in the liver. J Hepatol 48: 648-656, 2008.
21. Fornari F, Gramantieri L, Giovannini C, et al: MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res 69: 5761-5767, 2009.
22. Qu X, Zhai Y, Wei H, Zhang C, Xing G, Yu Y and He F: Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol Cell Biochem 229: 35-44, 2002. (Pubitemid 34187673)
23. Zhao W, Tang R, Huang Y, et al: Cloning and expression pattern of the human NDRG3 gene. Biochim Biophys Acta 1519: 134-138, 2001.
24. Wang W, Li Y, Li Y, Hong A, Wang J, Lin B and Li R: NDRG3 is an androgen-regulated and prostate-enriched gene that promotes in vitro and in vivo prostate cancer cell growth. Int J Cancer 124: 521-530, 2009.
25. Chattopadhyay S, Ely A, Bloom K, Weinberg MS and Arbuthnot P: Inhibition of hepatitis B virus replication with linear DNA sequences expressing antiviral micro-RNA shuttles. Biochem Biophys Res Commun 389: 484-489, 2009.
26. Liu YG, Liu SX, Liang XH, et al: Blockade of TRAIL pathway ameliorates HBV-induced hepatocyte apoptosis in an acute hepatitis model. Biochem Biophys Res Commun 352: 329-334, 2007.
27. Jopling CL, Yi M, Lancaster AM, Lemon SM and Sarnow P: Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309: 1577-1581, 2005. (Pubitemid 41266486)